Literature DB >> 20620423

The Abu Dhabi Cardiovascular Program: the continuation of Framingham.

Cother Hajat1, Oliver Harrison.   

Abstract

Sixty years on from its first publication, the Framingham study has made an historic impact in risk identification and prediction of cardiovascular disease (CVD) burden globally. The challenge for the 21st century is in finding practical and scalable methods for effective implementation of population-level interventions that are adaptable to low-, middle-, and high-income settings. Within its first 2 years, the Abu Dhabi Cardiovascular Program, "Weqaya," has delivered a Framingham Risk Score for almost every adult Emirati. This is complemented by a clear and progressive program including the health sector and societal approach to the delivery of interventions for CVD. The health sector response includes the use of clear, evidence-based standards of clinical care, customer-focused service innovation such as the use of mobile and wellness clinics, and attention to the patient experience, and improving compliance using a mixture of encourage, enable, and enforce mechanics. Components of the Abu Dhabi societal approach include "top-down" measures to align the civil sector response including use of policies and regulation, for example, for trade and urban planning. The "bottom-up" measures aim to empower individuals, groups, and populations. Key to the success of this approach lies in central coordination and routine monitoring and evaluation, incorporating the use of simple, shared metrics. The Abu Dhabi approach has created a solid platform for scalable intervention, and for "learning by doing," with impact being monitored at the level of individuals, groups and the whole population. The unique data architecture in Abu Dhabi will enable the first cardiovascular risk score to be developed for the region and the incorporation of novel, modifiable risk factors into the model. The last 2 years have seen huge progress in Abu Dhabi for CVD, but the coming 5 to 10 years promise to unearth real, large-scale solutions, building on the original Framingham model. Furthermore, the Abu Dhabi model is scalable and adaptable to low- and middle-income country settings. Local and global data on CVD risk are stark and raise a clear challenge for public health; the time for clear actions has arrived. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20620423     DOI: 10.1016/j.pcad.2010.05.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  11 in total

1.  The Prevention of Global Chronic Disease: Academic Public Health's New Frontier.

Authors:  Henry Greenberg; Susan U Raymond; Stephen R Leeder
Journal:  Am J Public Health       Date:  2011-06-16       Impact factor: 9.308

2.  Screening colonoscopy in the initial workup of bariatric surgery patients: guidelines are needed.

Authors:  Mohammed Al Hadad; Nidal Dehni; Abdullah Alakhras; Yalda Ziaei; Nicolas P Turrin; Abdelrahman Nimeri
Journal:  Surg Endosc       Date:  2014-01-08       Impact factor: 4.584

3.  Prevalence of undiagnosed diabetes and quality of care in diabetic patients followed at primary and tertiary clinics in Abu Dhabi, United Arab Emirates.

Authors:  Hussein Saadi; Jumaa Al-Kaabi; Mahmoud Benbarka; Ali Khalili; Wael Almahmeed; Nicolaas Nagelkerke; Laila Abdel-Wareth; Awad Al Essa; Javed Yasin; Bayan Al-Dabbagh; Elsadig Kazam
Journal:  Rev Diabet Stud       Date:  2011-02-10

4.  A profile and approach to chronic disease in Abu Dhabi.

Authors:  Cother Hajat; Oliver Harrison; Zainab Shather
Journal:  Global Health       Date:  2012-06-27       Impact factor: 4.185

5.  The burden of non-communicable disease in transition communities in an Asian megacity: baseline findings from a cohort study in Karachi, Pakistan.

Authors:  Faisal S Khan; Ismat Lotia-Farrukh; Aamir J Khan; Saad Tariq Siddiqui; Sana Zehra Sajun; Amyn Abdul Malik; Aziza Burfat; Mohammad Hussham Arshad; Andrew J Codlin; Belinda M Reininger; Joseph B McCormick; Nadeem Afridi; Susan P Fisher-Hoch
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

6.  Diagnostic testing for diabetes using HbA(1c) in the Abu Dhabi population: Weqaya: the Abu Dhabi cardiovascular screening program.

Authors:  Cother Hajat; Oliver Harrison; Zaid Al Siksek
Journal:  Diabetes Care       Date:  2011-09-16       Impact factor: 19.112

7.  Tobacco smoking using Midwakh is an emerging health problem--evidence from a large cross-sectional survey in the United Arab Emirates.

Authors:  Mohammed Al-Houqani; Raghib Ali; Cother Hajat
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

8.  Non-Communicable Disease Risk Factors among Employees and Their Families of a Saudi University: An Epidemiological Study.

Authors:  Rasmieh Alzeidan; Fatemeh Rabiee; Ahmed Mandil; Ahmad Hersi; Amel Fayed
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

9.  The Epidemiology and Economic Burden of Obesity and Related Cardiometabolic Disorders in the United Arab Emirates: A Systematic Review and Qualitative Synthesis.

Authors:  Hadia Radwan; Rami A Ballout; Hayder Hasan; Nader Lessan; Mirey Karavetian; Rana Rizk
Journal:  J Obes       Date:  2018-12-03

10.  Circulating levels of adiponectin and extent of coronary artery disease in patients undergoing elective coronary angiography.

Authors:  R A Souza; C M R Alves; C S V de Oliveira; A F Reis; A C Carvalho
Journal:  Braz J Med Biol Res       Date:  2017-11-30       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.